论文部分内容阅读
作者对比观察了善得定对急性胰腺炎的治疗作用，其剂量为０．１～０．１５ｍｇ，每４～６ｈ一次，皮下注射。在８５例水肿型胰腺炎中，１５例应用善得定治疗，结果显示，善得定治疗组转手术率显著低于非善得定组（Ｐ＜０．０５），未合并感染的１２例坏死性胰腺炎均采取非手术治疗，其中３例应用善得定治疗，其合并症全部消失，明显优于对照组。合并感染的６７例坏死性胰腺炎均予以手术治疗，病情严重的１４例，用善得定治疗，结果显示可减少并发症及其严重度。
The authors observed the good effect of the treatment of acute pancreatitis, the dose of 0.1 ~ 0.15mg, once every 4 ~ 6h, subcutaneous injection. Among 85 cases of edematous pancreatitis, 15 cases were treated with good-to-treat. The results showed that the rate of re-operation was significantly lower in the astragalus-treated group than in the non-good-to-decoction group (P <0.05) Necrotizing pancreatitis were taken non-surgical treatment, of which 3 cases of good use of fixed treatment, the complications disappeared, significantly better than the control group. Sixty-seven cases of necrotizing pancreatitis with infection were treated surgically, and 14 cases were seriously ill. Treatment with Sertraline showed that the complications and their severity could be reduced.